Global Retirement Partners’s XBiotech XBIT Stock Holding History

Global Retirement Partners’s Portfolio XBIT Stock Details XBIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-310	Closed	-$2K	–	1581
2018 Q1	$2K	Buy	+310	New	+$1.43K	﹤0.01%	1370

Other funds holding XBIT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ECM

Element Capital Management New York $1.05B AUM 5.05% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Global Retirement Partners's XBIT Position: Q2 2018 in Review

Global Retirement Partners sold out of XBiotech (XBIT) in Q2 2018, closing a stake of 310 shares — an estimated $2K sold.

Global Retirement Partners first reported a position in XBIT in Q1 2018 and held it in 1 quarter. The position peaked at $2K in Q1 2018. 31 funds tracked by Wall St. Rank hold XBIT as of Q2 2018.

Global Retirement Partners reported no remaining XBiotech position as of Q2 2018 after selling out during the quarter.
Global Retirement Partners sold 310 XBiotech shares in Q2 2018, an estimated $2K.
Global Retirement Partners first reported a position in XBiotech in Q1 2018 and held it in 1 quarter.
Global Retirement Partners's XBiotech position peaked at $2K in Q1 2018.
31 funds tracked by Wall St. Rank held XBiotech as of Q2 2018.

Based on Global Retirement Partners's 13F filing for Q2 2018, filed 13 Aug 2018.